School personnel information

写真b

MORII Eiichi


Mail Address

 Mail Address

URL

http://www.med.osaka-u.ac.jp/pub/molpath/

Gender

Male
To the head of this page.▲

Organization 【 display / non-display 】

  • 2001.08.01 - 2005.03.31, Graduate School of Medicine, Research Assistant

  • 2005.04.01 - 2006.07.31, Division of Pathophysiology and Therapeutics, Graduate School of Medicine, Research Assistant

  • 2006.08.01 - 2007.03.31, Osaka University Hospital, Associate Professor

  • 2007.04.01 - 2008.03.31, Osaka University Hospital, Associate Professor

  • 2008.04.01 - 2011.03.31, Division of Pathophysiology and Therapeutics, Graduate School of Medicine, Associate Professor

  • 2011.04.01 - 2012.04.30, Division of Medicine, Graduate School of Medicine, Associate Professor

  • 2012.05.01 - , Division of Medicine, Graduate School of Medicine, Professor

To the head of this page.▲

Education 【 display / non-display 】

Kyoto University Faculty of Pharmaceutical Science  Graduated 1988.03
Osaka University Faculty of Medicine  Graduated 1992.03
Osaka University Graduate School, Division of Medicine  Completed 1996.03
To the head of this page.▲
 

Academic Papers 【 display / non-display 】

  • Adult-onset biotinidase deficiency induces acutely progressing leukoencephalopathy, Beck G, Hirozawa D, Honma K, Baba K, Sumi H, Morii E, Murayama S, Mochizuki H, Neurology Clinical Practice, 2020.05, Papers

  • Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice., Tomohide Kurahashi, Yuichi Yoshida, Satoshi Ogura, Mayumi Egawa, Kunimaro Furuta, Hayato Hikita, Takahiro Kodama, Ryotaro Sakamori, Shinichi Kiso, Yoshihiro Kamada, I-Ching Wang, Hidetoshi Eguchi, Eiichi Morii, Yuichiro Doki, Masaki Mori, Vladimir V Kalinichenko, Tomohide Tatsumi, Tetsuo Takehara, Cellular and molecular gastroenterology and hepatology，9(3):425-446., 2020.04, Papers

  • Possible malignant transformation of arteriovenous malformation to angiosarcoma: case report and literature review, Tanaka Y, Seike S, Tomita K, Ikeda JI, Morii E, Isomura ET, Kubo T., J Surg Case Rep，2019(12):rjz375, 2019.12, Papers

  • Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth., Harada T, Matsumoto S, Hirota S, Kimura H, Fujii S, Kasahara Y, Gon H, Yoshida T, Itoh T, Haraguchi N, Mizushima T, Noda T, Eguchi H, Nojima S, Morii E, Fukumoto T, Obika S, Kikuchi A., Mol Cancer Ther.，18(3):602-612., 2019.03, Papers

  • Clinical Impact of the Location of Lymph Node Metastases After Neoadjuvant Chemotherapy for Middle and Lower Thoracic Esophageal Cancer., Miyata H, Sugimura K, Yamasaki M, Makino T, Tanaka K, Morii E, Omori T, Yamamoto K, Yanagimoto Y, Yano M, Nakatsuka S, Mori M, Doki Y., Ann Surg Oncol.，26(1):200-208, 2019.01, Papers

display all >>

To the head of this page.▲

Books 【 display / non-display 】

  • Special, Regulation of mast cell differentiation. In Histamine Research in New Millenium, Kitamura Y, Morii E, Ogihara H, Jippo T, and Ito A (eds, Watanabe T, Timmerman H, and Yanai K), Elsevier Science, Amsterdam, 2001.01

  • Special, Gain-of-function mutations of c-kit in human diseases. In Mast Cells and Basophils in Physiology, Pathology, and Host Defense, Kitamura Y, Hirota S, Morii E, and Nishida T(eds, Marone G, Lichtenstein LM, and Galli SJ), Academic Press, London, 2000.01

To the head of this page.▲